Department of Neurosurgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Cancer Med. 2018 Dec;7(12):5973-5987. doi: 10.1002/cam4.1853. Epub 2018 Oct 30.
The update of 2018 NCCN guidelines (central nervous system cancers) recommended the risk classification of postoperative patients diagnosed as adult low-grade (WHO grade II) infiltrative supratentorial astrocytoma/oligodendroglioma (ALISA/O) should take tumor size into consideration. Moreover, the guidelines removed postoperative radiotherapy (PORT) for low risk patients. Our study aimed to explore the specific tumor size to divide postoperative patients into relatively low- or high risk subgroups and the effect of PORT for ALISA/O patients.
We conducted a retrospective study choosing 1277 postoperative ALISA/O patients from the Surveillance, Epidemiology, and End Results database. The X-tile analysis provided the optimal cutoff point based on tumor size. The differences between surgery alone and surgery +RT groups were balanced by propensity score-matched analysis. The multivariable analysis and the nomogram evaluated multiple prognostic factors based on cancer-specific survival (CSS) and overall survival (OS).
X-tile plots defined 59 mm (P < 0.001) as the optimal cutoff tumor size value in terms of CSS, which was verified in multivariate analysis (P < 0.001). The Kaplan-Meier analysis showed that the surgery alone had higher CSS and OS than surgery +RT, while the low risk group had no statistical significance after propensity score match. Multivariable analysis showed that surgery +RT was independently associated with diminished OS and CSS for high risk group, which had no statistical significance for low-risk group.
Our study suggested that tumor size of 59 mm was an optimal cutoff point to divide postoperative patients into relatively low- or high risk subgroups. PORT may not benefit patients, while the effects of PORT for low risk patients need further research.
2018 年 NCCN 指南(中枢神经系统肿瘤)更新版建议,对于术后诊断为成人低级别(世界卫生组织[WHO] 分级 II 级)浸润性幕上星形细胞瘤/少突胶质细胞瘤(ALISA/O)的患者,风险分类应考虑肿瘤大小。此外,指南取消了低危患者的术后放疗(PORT)。本研究旨在探讨将术后患者分为相对低危或高危亚组的具体肿瘤大小,并评估 PORT 对 ALISA/O 患者的影响。
我们进行了一项回顾性研究,从监测、流行病学和最终结果数据库中选择了 1277 例术后 ALISA/O 患者。X-tile 分析基于肿瘤大小提供最佳截断点。通过倾向评分匹配分析平衡手术与手术+RT 组之间的差异。多变量分析和列线图根据癌症特异性生存(CSS)和总生存(OS)评估多个预后因素。
X-tile 图定义 59mm(P<0.001)为 CSS 的最佳截断肿瘤大小值,这在多变量分析中得到验证(P<0.001)。Kaplan-Meier 分析显示,手术组的 CSS 和 OS 高于手术+RT 组,而倾向评分匹配后低危组无统计学意义。多变量分析显示,手术+RT 与高危组的 OS 和 CSS 降低独立相关,而低危组无统计学意义。
我们的研究表明,肿瘤大小为 59mm 是将术后患者分为相对低危或高危亚组的最佳截断点。PORT 可能对患者无益,而 PORT 对低危患者的影响需要进一步研究。